COMPANY

PAI Life Sciences Inc.

HQ: Seattle, WA source · pailifesciences.com ↗ · West Coast

Location: Seattle, WA · source · Oct 15, 2026

Profile checked Oct 10, 2026

41NIH grants

Funding and NIH signals

NIH award NIH awarded $391K (SBIR Phase I 1R43CA298357-01A1, new, notice Sep 17, 2026); 2 NIH awards totaling $1.11M in the last 12 months. NIH RePORTER 1R43CA298357-01A1 (Sep 17, 2026)
Evidence (2 events)
- Sep 17, 2026 · NIH RePORTER 1R43CA298357-01A1
  Organization: PAI LIFE SCIENCES, INC.; City/State: SEATTLE, WA; Project number: 1R43CA298357-01A1; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 391300; Administering IC: National Cancer Institute; Project title: LiT4Q TLR4 Agonist Formulation for Mucosal Melanoma; Organization type: Domestic For-Profits
- May 19, 2026 · NIH RePORTER 5R44AI140708-07
  Organization: PAI LIFE SCIENCES, INC.; City/State: SEATTLE, WA; Project number: 5R44AI140708-07; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-05-19; FY total cost (award amount): 713883; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: A Vaccine for Lymphatic Filariasis, LFGuard™; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Sep 17, 2026 Grant Government grant — SBIR: $391,300 (annual award, as published), announced Sep 17, 2026. Agency: NIH/NCI. Source: government award database. source ↗
May 19, 2026 Grant Government grant — SBIR: $713,883 (annual award, as published), announced May 19, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Mar 21, 2025 Grant Government grant — SBIR: $452,996 (annual award, as published), announced Mar 21, 2025. Agency: NIH/NIAID. Source: government award database. source ↗

Funding

Last 2 years.

Sep 17, 2026 Government grant — SBIR: $391,300 (annual award, as published), announced Sep 17, 2026. Agency: NIH/NCI. Source: government award database. source ↗
May 19, 2026 Government grant — SBIR: $713,883 (annual award, as published), announced May 19, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Mar 21, 2025 Government grant — SBIR: $452,996 (annual award, as published), announced Mar 21, 2025. Agency: NIH/NIAID. Source: government award database. source ↗

NIH awards 41

Annual award amounts. Total $23.7M.

Jan 3, 2024 NIH award 1R41AI181069-01 FY2024: $295,386 awarded for that fiscal year; activity R41 (STTR); PI GRAY, SEAN ALEX; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. Antigen and adjuvant selection for a vacci source ↗
Dec 8, 2023 NIH award 2R44AI140708-05 FY2024: $995,460 awarded for that fiscal year; activity R44 (SBIR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. A Vaccine for Lymphatic Filariasis, source ↗
Sep 12, 2023 NIH award 1R43AI179364-01 FY2023: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI GRAY, SEAN ALEX; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. Evaluation of a Next Generation SchistoShi source ↗
May 18, 2022 NIH award 5R44AI140708-04 FY2022: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. A Vaccine for Lymphatic Filariasi source ↗
Feb 3, 2022 NIH award 5R44AI103983-08 FY2022: $506,495 awarded for that fiscal year; activity R44 (SBIR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. A Vaccine for Schistosomiasis, "Sch source ↗
2022 NIH contract (government contract; not a grant and not an investment round) 75N93022C00004-0-9999-1 FY2022: $597,953 awarded for that fiscal year; activity N43 (OTHER_NIH); PI CARTER, DARRICK; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. LATE ST source ↗
Sep 8, 2021 NIH award 1R43IP001164-01 FY2021: $243,000 awarded for that fiscal year; activity R43 (SBIR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. Adjuvanted Recombinant Candidates t source ↗
May 21, 2021 NIH award 5R44AI140708-03 FY2021: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. A Vaccine for Lymphatic Filariasi source ↗
Apr 26, 2021 NIH award 5R21AI151824-02 FY2021: $86,791 awarded for that fiscal year; activity R21 (OTHER_NIH); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. Developing a Screen for New Adj source ↗
Feb 4, 2021 NIH award 5R44AI103983-07 FY2021: $506,495 awarded for that fiscal year; activity R44 (SBIR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. A Vaccine for Schistosomiasis, "Sch source ↗
Aug 26, 2020 NIH award 5R44CA206607-03 FY2020: $556,615 awarded for that fiscal year; activity R44 (SBIR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. JOC-x: Chemotherapy conjugates that source ↗
Jun 23, 2020 NIH award 2R44AI140708-02 FY2020: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. A Vaccine for Lymphatic Filariasi source ↗
Jun 11, 2020 NIH award 1R21AI151824-01 FY2020: $290,045 awarded for that fiscal year; activity R21 (OTHER_NIH); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. Developing a Screen for New Ad source ↗
Mar 12, 2020 NIH award 2R44AI103983-06A1 FY2020: $706,627 awarded for that fiscal year; activity R44 (SBIR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. A Vaccine for Schistosomiasis, "S source ↗
Sep 19, 2019 NIH award 2R44CA206607-02A1 FY2019: $720,945 awarded for that fiscal year; activity R44 (SBIR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. JOC-x: Chemotherapy conjugates th source ↗
Feb 27, 2019 NIH award 1R43AI140708-01A1 FY2019: $224,988 awarded for that fiscal year; activity R43 (SBIR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. Process Development for a Lymphat source ↗
2019 NIH contract (government contract; not a grant and not an investment round) 75N93019C00028-0-9999-1 FY2019: $2,961,685 awarded for that fiscal year; activity N44 (OTHER_NIH); PI CARTER, DARRICK; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. Phase source ↗
2019 NIH contract (government contract; not a grant and not an investment round) 75N93019C00008-0-9999-1 FY2019: $299,184 awarded for that fiscal year; activity N43 (OTHER_NIH); PI KHANDHAR, AMIT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. A Self-R source ↗
Nov 19, 2018 NIH award 1R43AI142908-01 FY2019: $224,999 awarded for that fiscal year; activity R43 (SBIR); PI GRAY, SEAN ALEX; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. Production and Validation of Sj-p80 as a V source ↗
Dec 29, 2017 NIH award 5R44AI103983-05 FY2018: $1,288,089 awarded for that fiscal year; activity R44 (SBIR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. A Vaccine for Schistosomiasis, "S source ↗
Jul 26, 2017 NIH award 1R41AI134271-01 FY2017: $157,401 awarded for that fiscal year; activity R41 (STTR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. CruziScreen, a recombinant antigen- source ↗
Mar 14, 2017 NIH award 1R43AI127053-01A1 FY2017: $224,998 awarded for that fiscal year; activity R43 (SBIR); PI VAN HOEVEN, NEAL SCOTT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. Development of an Innovative, Eff source ↗
Dec 30, 2016 NIH award 5R44AI103983-04 FY2017: $1,380,664 awarded for that fiscal year; activity R44 (SBIR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. A Vaccine for Schistosomiasis, "S source ↗
Sep 20, 2016 NIH award 1R43CA206607-01A1 FY2016: $199,997 awarded for that fiscal year; activity R43 (SBIR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. JOC-x: Chemotherapy conjugates th source ↗
Feb 26, 2016 NIH award 1R43HL131195-01 FY2016: $208,639 awarded for that fiscal year; activity R43 (SBIR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. A recombinant protein that increase source ↗
2016 NIH contract (government contract; not a grant and not an investment round) 272201600036C-0-0-1 FY2016: $444,428 awarded for that fiscal year; activity N43 (OTHER_NIH); PI COLER, RHEA; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. COMBINING PARAS source ↗
2016 NIH contract (government contract; not a grant and not an investment round) 272201600037C-0-0-1 FY2016: $441,905 awarded for that fiscal year; activity N43 (OTHER_NIH); PI CARTER, DARRICK; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. DEVELOPMENT source ↗
Dec 29, 2015 NIH award 2R44AI103983-03A1 FY2016: $1,159,786 awarded for that fiscal year; activity R44 (SBIR); PI CARTER, DARRICK ALBERT; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. A Vaccine for Schistosomiasis, source ↗
Jun 15, 2015 NIH award 5R43AI109936-02 FY2015: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI COLER, RHEA N; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. Immuno-Chemotherapy to Shorten TB Treatment source ↗
2015 NIH contract (government contract; not a grant and not an investment round) 272201500030C-0-0-1 FY2015: $1,486,937 awarded for that fiscal year; activity N44 (OTHER_NIH); PI CARTER, DARRICK; recipient as written: PAI LIFE SCIENCES, INC., SEATTLE, WA. INHALED D source ↗